AI Powers Microsoft's Q1 Growth, but Stock Falls on Guidance. Is It Now a No-Brainer Buy?

The Motley Fool
Updated
Mitrade
coverImg
Source: Shutterstock

Microsoft's (NASDAQ: MSFT) cloud computing platform Azure continued to be the growth driver for the stock when the software giant reported its fiscal Q1 earnings. However, the company's guidance for Azure, while strong, left investors wanting more.


The decline in its share price following the report's release on Wednesday leaves Microsoft stock up only around 10% on the year. Let's take a closer look at the company's results to see if this is a good opportunity to buy the dip.


Azure revenue accelerates


Azure was once again Microsoft's growth engine, with year-over-year revenue growth of 33% (34% in constant currency), which was an acceleration from the 29% (30% in constant currency) growth it saw last quarter. The revenue growth was well above the 28% to 29% constant currency growth the company had previously forecast.


Microsoft credited the strong growth to Azure OpenAI usage, which has doubled in the last six months, as it helps customers build their own artificial intelligence (AI) agents and copilots. It also said that Azure AI is feeding into increased usage of its data and analytics services.


However, investors were disappointed that company management only forecasted Azure revenue to grow by 31% to 32% in constant currency in its fiscal Q2. This is despite the company saying growth would accelerate in the second half of its fiscal year as its prior capital expenditures (capex) create more capacity to meet the strong demand it is seeing.


Overall Intelligent Cloud revenue, where Azure resides, climbed 20% year over year to $24.1 billion.


Looking at Microsoft's other segments, Productivity and Business Processes, which is where Office and LinkedIn reside, saw revenue jump 12% year over year to $28.3 billion. Dynamics 365 and Office 365 Commercial led the way with revenue growth of 14% and 13%, respectively, while LinkedIn revenue grew 10% and Office 365 Consumer revenue rose 5%.


Microsoft said its Copilot 365 AI agents continue to see swift adoption, with more than 70% of the Fortune 500 using the tools. Meanwhile, it said the adoption of copilots for ERP and CRM systems has been helping power the results at Dynamics.


Revenue in its More Personal Computing segment, home to Windows and Xbox, jumped 17% year over year to $13.2 billion. Microsoft's recent acquisition of video game maker Activision helped power the results, while search and news advertising revenue was strong.


Overall, Microsoft's revenue climbed 16% year over year to $65.6 billion, with earnings per share (EPS) up 10% to $3.30. The results were solidly ahead of analyst expectations, topping the consensus for $64.5 billion in revenue and $3.10 in EPS, as compiled by LSEG.


Looking ahead, Microsoft forecast its Intelligent Cloud segment to grow between 18% and 20% in constant currency, while its Productivity and Business Processes segment revenue is projected to increase by between 10% and 11% in constant currency. More Personal Computing is forecast to decline by 16% to 18%.

Artist rendering of cloud computing and AI with brain on computer.

Image source: Getty Images.


Is it time to buy the dip?


While investors were disappointed with Azure guidance, the only thing that appears to be keeping growth back at the segment is capacity constraints, which the company is spending money on to alleviate. Meanwhile, Azure growth in the quarter came in much higher than it previously projected, so there is certainly room for it to outperform. Right now, though, Azure is a growth machine for Microsoft and there is no indication that it will slow down.


Meanwhile, its other businesses are, by and large, showing solid growth. GitHub continues to be strong, and the company has a huge opportunity with its Microsoft 365 copilots. The company recently introduced the newest versions of the AI agents that work with Office 365, and early uptake appears strong. Given the add-on's price point of $30 per month per user for enterprise customers, this should be a big revenue driver for the company in the coming years.


The stock now trades at a forward price-to-earnings (P/E) ratio of under 27, which is below where it has traded for much of the year. That may not be on the clearance rack, but that's an attractive valuation for a company with a solid recurring revenue stream and a lot of AI opportunities in front of it.


MSFT PE Ratio (Forward 1y) Chart

MSFT PE Ratio (Forward 1y) data by YCharts


Microsoft has already been a big AI winner with Azure, which looks like it should continue. Meanwhile, if AI can help supercharge growth for Office 365, then the stock has a lot more upside from here.


All in all, I think the market reaction to Microsoft's earnings was an overreaction and this looks like a great opportunity for long-term investors to buy the stock on the dip.

* The content presented above, whether from a third party or not, is considered as general advice only.  This article should not be construed as containing investment advice, investment recommendations, an offer of or solicitation for any transactions in financial instruments.

goTop
quote
Do you find this article useful?
Related Articles
placeholder
India’s economy is tumbling, and it might take whole world down with itIndia’s economy is spiraling. The rupee is sinking like a stone, dragging with it a mix of trade deficits, shrinking capital inflows, and uncertainty. The country’s economy has quickly become so important that if it plummets, the global economy will be at stake.
Author  Cryptopolitan
8 hours ago
India’s economy is spiraling. The rupee is sinking like a stone, dragging with it a mix of trade deficits, shrinking capital inflows, and uncertainty. The country’s economy has quickly become so important that if it plummets, the global economy will be at stake.
placeholder
Down 19% in 1 Day, Is Novo Nordisk Stock Still a Buy?Amidst a race with its competitors to produce the next smash-hit weight loss drug, Novo Nordisk's (NYSE: NVO) stock crashed by 19% on Dec. 20, after the company reported results from a late-stage clinical trial that it framed as a success.
Author  The Motley Fool
8 hours ago
Amidst a race with its competitors to produce the next smash-hit weight loss drug, Novo Nordisk's (NYSE: NVO) stock crashed by 19% on Dec. 20, after the company reported results from a late-stage clinical trial that it framed as a success.
placeholder
Novo Nordisk Sees Retail Buying Despite Wall Street CutsShares of leading weight-loss drugmaker Novo Nordisk (NVO.US) plunged after disappointing results from its latest weight-loss drug trial. Despite analysts slashing their price targets, retail investors flooded into the stock with massive buy-the-dip activity.
Author  Mitrade
13 hours ago
Shares of leading weight-loss drugmaker Novo Nordisk (NVO.US) plunged after disappointing results from its latest weight-loss drug trial. Despite analysts slashing their price targets, retail investors flooded into the stock with massive buy-the-dip activity.
placeholder
The Year of Concentration, Crypto, ChinaWhy 2024 was such a good year for investors, and the concerns they have about valuations and market concentration as they look ahead to 2025.
Author  The Motley Fool
15 hours ago
Why 2024 was such a good year for investors, and the concerns they have about valuations and market concentration as they look ahead to 2025.
placeholder
Prediction: This Energy Stock Will Deliver Substantial Market-Beating ReturnsExplore the exciting world of Chart Industries (NYSE: GTLS) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!
Author  The Motley Fool
15 hours ago
Explore the exciting world of Chart Industries (NYSE: GTLS) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!